We show here that p73 acts as a T cell-specific tumor suppressor in a genetically defined mouse model, and that concomitant ablation of p53 and p73 predisposes mice to an increased incidence of thymic tumors compared to the loss of p53 alone. The gene discussed is TP53; the disease is thymus neoplasm.